Laurel Copeland to Schizophrenia
This is a "connection" page, showing publications Laurel Copeland has written about Schizophrenia.
Connection Strength
2.369
-
Tsan JY, Stock EM, Gonzalez JM, Greenawalt DS, Zeber JE, Rouf E, Copeland LA. Mortality and guideline-concordant care for older patients with schizophrenia: a retrospective longitudinal study. BMC Med. 2012 Nov 26; 10:147.
Score: 0.349
-
Copeland LA, Parchman ML, Zeber JE, Lawrence VA, Downs JR, Miller AL. Prediabetes assessment and follow-up in older veterans with schizophrenia. Am J Geriatr Psychiatry. 2010 Oct; 18(10):887-96.
Score: 0.301
-
Copeland LA, Zeber JE, Wang CP, Parchman ML, Lawrence VA, Valenstein M, Miller AL. Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Serv Res. 2009 Jul 26; 9:127.
Score: 0.277
-
Copeland LA, Zeber JE, Pugh MJ, Mortensen EM, Restrepo MI, Lawrence VA. Postoperative complications in the seriously mentally ill: a systematic review of the literature. Ann Surg. 2008 Jul; 248(1):31-8.
Score: 0.257
-
Copeland LA, Mortensen EM, Zeber JE, Pugh MJ, Restrepo MI, Dalack GW. Pulmonary disease among inpatient decedents: Impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13; 31(3):720-6.
Score: 0.232
-
Copeland LA, Zeber JE, Rosenheck RA, Miller AL. Unforeseen inpatient mortality among veterans with schizophrenia. Med Care. 2006 Feb; 44(2):110-6.
Score: 0.218
-
Copeland LA, Zeber JE, Valenstein M, Blow FC. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry. 2003 Oct; 160(10):1817-22.
Score: 0.185
-
Owen-Smith A, Stewart C, Green C, Ahmedani BK, Waitzfelder BE, Rossom R, Copeland LA, Simon GE. Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness. Gen Hosp Psychiatry. 2016 Jan-Feb; 38:9-14.
Score: 0.105
-
Phillips KL, Copeland LA, Zeber JE, Stock EM, Tsan JY, MacCarthy AA. Racial/Ethnic disparities in monitoring metabolic parameters for patients with schizophrenia receiving antipsychotic medications. Am J Geriatr Psychiatry. 2015 Jun; 23(6):596-606.
Score: 0.098
-
Sun F, Stock EM, Copeland LA, Zeber JE, Ahmedani BK, Morissette SB. Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems. Am J Health Syst Pharm. 2014 May 01; 71(9):728-38.
Score: 0.096
-
Maples NJ, Copeland LA, Zeber JE, Li X, Moore TA, Dassori A, Velligan DI, Miller AL. Can medication management coordinators help improve continuity of care after psychiatric hospitalization? Psychiatr Serv. 2012 Jun; 63(6):554-60.
Score: 0.084
-
Dassori AM, Copeland LA, Zeber JE, Miller AL. Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia. Psychiatr Serv. 2011 Jan; 62(1):47-53.
Score: 0.076
-
Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull. 2004; 30(2):255-64.
Score: 0.047
-
Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care. 2002 Aug; 40(8):630-9.
Score: 0.043